Similar articles

• The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast cancer in Australian women.

  Spurdle AB, Hopper JL, Chen X, McCredie MR, Giles GG, Venter DJ, Southey MC, Chenevix-Trench G. Spurdle AB, et al. Cancer Epidemiol Biomarkers Prev. 2002 May;11(5):439-43. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12010857
• Vitamin D receptor gene polymorphisms and breast cancer risk.

  Guy M, Lowe LC, Bretherton-Watt D, Mansi JL, Peckitt C, Bliss J, Wilson RG, Thomas V, Colston KW. Guy M, et al. Clin Cancer Res. 2004 Aug 15;10(16):5472-81. doi: 10.1158/1078-0432.CCR-04-0206. Clin Cancer Res. 2004. PMID: 15328186
• Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women.

  Suter NM, Malone KE, Daling JR, Doody DR, Ostrander EA. Suter NM, et al. Cancer Epidemiol Biomarkers Prev. 2003 Feb;12(2):127-35. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 12582022
• Vitamin D receptor polymorphisms and breast cancer risk: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.

  McKay JD, McCullough ML, Ziegler RG, Kraft P, Saltzman BS, Riboli E, Barricarte A, Berg CD, Bergland G, Bingham S, Brustad M, Bueno-de-Mesquita HB, Burdette L, Buring J, Calle EE, Chanock SJ, Clavel-Chapelon F, Cox DG, Dossus L, Feigelson HS, Haiman CA, Hankinson SE, Hoover RN, Hunter DJ, Husing A, Kaaks R, Kolonel LN, Le Marchand L, Linseisen J, McCarty CA, Overvad K, Panico S, Purdue MP, Stram DO, Stevens VL, Trichopoulos D, Willett WC, Yuenger J, Thun MJ. McKay JD, et al. Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):297-305. doi: 10.1158/1055-9965.EPI-08-0539. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19124512
• Familial breast cancer.

  Evans DG, Fentiman IS, McPherson K, Asbury D, Ponder BA, Howell A. Evans DG, et al. BMJ. 1994 Jan 15;308(6922):183-7. doi: 10.1136/bmj.308.6922.183. BMJ. 1994. PMID: 8312772 Free PMC article. Review. No abstract available.